Dr. Yarema Bezchlibnyk, MD
Claim this profileTampa General Hospital
Studies Alzheimer's Disease
Studies Dystonia
6 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Yarema Bezchlibnyk, MD is currently running
ExAblate BBB Disruption
for Alzheimer's Disease
This trial is testing a device that uses ultrasound waves to temporarily open the brain's protective barrier in patients with Alzheimer's Disease. The goal is to see if this can help medications reach the brain better. Focused ultrasound with microbubbles has been studied recently and shows promise for opening the brain's protective barrier in Alzheimer's disease treatment.
Recruiting1 award N/A5 criteria
Vagus Nerve Stimulation
for Rheumatoid Arthritis
The RESET-RA study will assess the safety and efficacy of the SetPoint System (study device) for the treatment of adult patients with active, moderate to severe rheumatoid arthritis who have had an inadequate response or intolerance to biologic or targeted synthetic Disease-Modifying Anti-Rheumatic Drugs (DMARDs). The study device contains a miniaturized stimulator (implant) that is surgically placed under general anesthesia on the vagus nerve through a small incision on the left side of the neck (implant procedure). The study will enroll 250 subjects at 40 sites. All eligible subjects will undergo the implant procedure. Half of the subjects will receive active stimulation (treatment) and the other half will receive non-active stimulation (control). After completing primary endpoint assessments at Week 12, there will be a one-way crossover of control subjects to active stimulation and a 180-week open-label follow-up with all subjects (treatment and control) receiving active stimulation to evaluate long-term safety.
Recruiting1 award Phase 34 criteria
More about Yarema Bezchlibnyk, MD
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Yarema Bezchlibnyk, MD has experience with
- Abbott DBS
- SetPoint System
- Neuro-Spinal Scaffold
- Exablate Model 4000
- ExAblate Model 4000 Type 2.0 System
- DBS-f
Breakdown of trials Yarema Bezchlibnyk, MD has run
Alzheimer's Disease
Parkinson's Disease
Movement Disorders
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yarema Bezchlibnyk, MD specialize in?
Yarema Bezchlibnyk, MD focuses on Alzheimer's Disease and Dystonia. In particular, much of their work with Alzheimer's Disease has involved treating patients, or patients who are undergoing treatment.
Is Yarema Bezchlibnyk, MD currently recruiting for clinical trials?
Yes, Yarema Bezchlibnyk, MD is currently recruiting for 3 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Yarema Bezchlibnyk, MD has studied deeply?
Yes, Yarema Bezchlibnyk, MD has studied treatments such as Abbott DBS, SetPoint System, Neuro-Spinal Scaffold.
What is the best way to schedule an appointment with Yarema Bezchlibnyk, MD?
Apply for one of the trials that Yarema Bezchlibnyk, MD is conducting.
What is the office address of Yarema Bezchlibnyk, MD?
The office of Yarema Bezchlibnyk, MD is located at: Tampa General Hospital, Tampa, Florida 33606 United States. This is the address for their practice at the Tampa General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.